Abstract

Simple SummaryWhile previous studies have suggested that HPV-associated head and neck cancer (HNC) is mostly in the younger population, we found that in the last 40 years, the mean age at diagnosis of oropharyngeal cancer has been 60.3 years. We found that after an initially decrease leading up to the early 2000s, there has been a steady increase in age at diagnosis of oropharyngeal cancer since 2002. For non-oropharyngeal HNC, mean age at diagnosis has steadily increased throughout the last four decades. Finally, we found that age at diagnosis of HNC is higher among females in general, and lowest among blacks.The emergence of the human papillomavirus (HPV) as the primary etiology of oropharyngeal cancer has changed head and neck cancer (HNC) epidemiology. This study described change in the age at diagnosis of oropharyngeal and non-oropharyngeal HNC in the United States in the last four decades. Using a retrospective cohort analysis, the Surveillance, Epidemiology, and End Results dataset from 1975 to 2016 was queried for eligible adult cases of HNC, grouped as oropharyngeal (n = 31,702) versus non-oropharyngeal (n = 87,108). Age at diagnosis was compared by gender (female, male) using independent t-test, and by race/ethnicity (Hispanic, non-Hispanic black, non-Hispanic white, non-Hispanic other) using analysis of variance. Joinpoint regression estimated yearly increases/decreases in age of diagnosis by sex and race/ethnicity through annual percent changes (APC), which were summarized with average annual percent changes (AAPC). Mean age at diagnosis for oropharyngeal cancer was 60.3 years. While there was initially a decrease in age at diagnosis, a 0.37% annual increase occurred from 2002 to 2016 (APC = 0.37, 95% confidence interval (CI) 0.28, 0.45). For non-oropharyngeal cancer, mean age at diagnosis was 63.2 years, with a continuous increase in age at diagnosis throughout the study period (1975–2016 AAPC = 0.08, 95% CI 0.04, 0.12). Females had higher average age at diagnosis than males for both sites, while blacks (57.4 years for oropharyngeal cancer; 59.0 years for non-oropharyngeal) had the lowest age at diagnosis of all races/ethnicity. Age at diagnosis of oropharyngeal cancer has increased significantly since 2002, while non-oropharyngeal HNC has increased significantly in the last four decades.

Highlights

  • The epidemiology of head and neck cancer (HNC) has evolved over time, mostly due to the decrease in smoking rates, and the concomitant emergence of the human papillomavirus (HPV) as the most common etiology of oropharyngeal cancer [1] HPV is linked to 70–90% of oropharyngeal cancer cases [2] and HPV-associated oropharyngeal cancer has increased in incidence in the United States between 54–225% in the last three decades [2,3,4,5]

  • The current study builds on recent studies [18,19,20,21,22], uses population-based cancer data, and tests the hypothesis that change in age at diagnosis of HNC in the United States in the last four decades differs based on race and gender as well oropharyngeal cancer status

  • The average age at diagnosis over the entire study period was significantly lower for oropharyngeal cancer (60.3 years) compared with other HNC (63.2 years) (p < 0.01)

Read more

Summary

Introduction

The epidemiology of head and neck cancer (HNC) has evolved over time, mostly due to the decrease in smoking rates, and the concomitant emergence of the human papillomavirus (HPV) as the most common etiology of oropharyngeal cancer [1] HPV is linked to 70–90% of oropharyngeal cancer cases [2] and HPV-associated oropharyngeal cancer has increased in incidence in the United States between 54–225% in the last three decades [2,3,4,5]. HPV-associated oropharyngeal cancer has surpassed cervical cancer as the leading HPV-associated cancer in the United States, and this number is expected to continue to grow [6,7,8] This changing epidemiology of HNC has been associated with a change in the age at diagnosis, with several studies describing a shift from age of diagnosis in the sixth or seventh decade of life to an increasing incidence of HNC diagnosed in patients younger than 60 years, both in oropharyngeal and non-oropharyngeal cases [9,10,11,12,13,14,15,16,17]. The current study builds on recent studies [18,19,20,21,22], uses population-based cancer data, and tests the hypothesis that change in age at diagnosis of HNC in the United States in the last four decades differs based on race and gender as well oropharyngeal cancer status

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.